Summit Therapeutics Inc. (SMMT) - 1100% jump in weekly message volume The biopharma company saw a sharp rise in retail ...

Seaport Res Ptn currently has a “Strong-Buy” rating on the stock. The consensus estimate for Avient’s current full-year earnings is $2.85 per share. Seaport Res Ptn also issued estimates for ...

Patronus Resources (ASX: PTN) has announced the delineation of a new 1km-long gold trend at its Cardinia East Project near ...

A downtrend has been apparent in Palatin Technologies, Inc. (PTN) lately. While the stock has lost 9.3% over the past week, it could witness a trend reversal as a hammer chart pattern was formed ...

Palatin Technologies, Inc. (the "Company") (NYSE American: PTN), a biopharmaceutical company developing first-in-class ...

Technologies announced today that on April 10, NYSE American publicly announced and provided a notice to the company that NYSE ...

Seaport Res Ptn has a “Strong-Buy” rating on the stock. The consensus estimate for D.R. Horton’s current full-year earnings is $13.04 per share. Seaport Res Ptn also issued estimates for D.R ...

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company’s lead product ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...